BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2004
View Archived Issues
In vivo characterization of a rapid-acting thyroid hormone derivative
Read More
Chemokine microbicide formulation effective against HIV-1 in macaques
Read More
Influenza vaccine from Aventis now available for shipping
Read More
Dual neuroprotection from oxygen and nitrogen reactive species
Read More
PEP-005 shows high selectivity against leukemia
Read More
New phase I study of AT-1001 for Fabry's disease
Read More
Phase I studies begin for ABT-894 for neuropathic pain
Read More
OrthoLogic completes acquisition of Chrysalis BioTechnology
Read More
New indication approved for Hyzaar
Read More
European recommendation for extended dosing of Aranesp
Read More
GlycoGenesys enters agreements to close on funding from institutions
Read More
Yakult Honsha and Taiho to copromote oxaliplatin in Japan
Read More
Portola licenses Millennium's Factor Xa inhibitor program
Read More
Five series of chemokine CCR5 antagonists presented by GSK
Read More
AstraZeneca presents novel GSK-3 inhibitors for AD and other uses
Read More
Japanese researchers prepare and test a new antineoplastic antibiotic
Read More
New KDR and FGFR inhibitors with potential in solid tumor therapy
Read More
New epothilone derivatives in early development at Novartis
Read More
New glucagon antagonists discovered by Novo Nordisk scientists
Read More
Novel PAI-1 inhibitors produced by the microorganism Stachybotris atra
Read More
Human multidrug resistance protein 1 targeted in malignant cells
Read More
Frovatriptan provides relief for menstrual associated migraine
Read More
Merck & Co. and DOV enter agreement for triple uptake inhibitor development
Read More
NPS to promote Amgen's Kineret to rheumatologists
Read More
Approvable letter for ZyLET
Read More
Sinovac's phase I SARS study progresses
Read More
Dosing begins in phase I study of the thrombin inhibitor ARC-183
Read More
